Otivio AS is a privately owned med tech development company based in Oslo, Norway. The company was founded in 2010. Our vision is to stimulate active self care and treatment through simple and easy to use home treatment devices and services.

FlowOx is a Pulsating Negative Pressure Therapy. It is a CE marked non-invasive medical device addressing insufficient blood flow to the limbs associated with peripheral arterial disease, diabetes and other medical conditions. These conditions lead to pain, chronic wounds and amputations. FlowOx 2.0 is a novel Class IIa Medical Device. It is comfortable, it can be used while patients are at rest. It can transiently increase blood flow in lower extremities by about 60% in the small arteries and more than 100% in the capillaries. 

FlowOx is documented to reduce or eliminate these outcomes which represent a big impact on Quality of Life and health care costs. FlowOx represents a solution for transition from hospital to home treatment accentuated by the COVID-19 outbreak.